PharmaCyte Biotech, Inc. (PMCB) stock
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.42−0.15 (-2.69%)
Close on Nov 17, 2026Market cap $58.19MP/E –Yield –
PharmaCyte Biotech gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2013 it was 20.9%, against 70.9% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2013 | Apr 30, 2013 | 20.9% | −50.0 |
| FY2012 | Apr 30, 2012 | 70.9% | −3.6 |
| FY2011 | Apr 30, 2011 | 74.5% | – |
See a number that looks wrong?